A review of ethical considerations for ventricular assist device placement in older adults

Aging and Disease

Volumn 4, Issue 2, 2013, Pages 100-112

  Bruce, Courtenay R ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Ethics; haseart failure; Mechanical support; Older adults; Ventricular assist devices

Indexed keywords

EID: 84890330459     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Rich MW (2006). Heart failure in older adults. Med Clin North Am, 90: 863.
2. Kirkpatrick JN, Kim AY (2006). Ethical issues in heart failure: overview of an emerging need. Perspect Biol Med, 49: 1-9.
3. Rogers JG, Milano CA (2012). Ramping up evidence-based ventricular assist device care. J Am Coll Cardiol, 60: 1776-1777.
4. Fields AV, Kirkpatrick JN (2012). Ethics of the heart: ethical and policy challenges in the treatment of advanced heart failure. Perspect Biol Med, 55: 71-80.
5. O'Connell JB (2000). The economic burden of heart failure. Clin Cardiol, 23: III6-10.
6. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al (2001). ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation, 104: 2996-3007.
7. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV (2003). Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA, 290: 2581-2587.
8. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al (2008). Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 117: e25-146.
9. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al (2001). Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med, 344:1651-1658.
10. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al (2001). Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med, 345: 1435-1443.
11. SOLVD Investigators (1991). Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med, 325: 293-302.
12. Frazier OH, Myers TJ, Jarvik RK, Westaby S, Pigott DW, Gregoric ID, et al (2001). Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart. Ann Thorac Surg, 71: S125-132; discussion S144-146.
13. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al (2009). Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med, 361: 2241-2251.
14. Long JW, Healy AH, Rasmusson BY, Cowley CG, Nelson KE, Kfoury AG, et al (2008). Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg, 135: 1353-1360.
15. Grady KL, Warner Stevenson L, Pagani FD, Teuteberg J, Pamboukian SV, Birks E, et al (2012). Beyond survival: Recommendations from INTERMACS for assessing function and quality of life with mechanical circulatory support. J Heart Lung Transplant, 31: 1158-1164.
16. Marcus P (2009). Left ventricular assist devices: psychosocial challenges in the elderly. Ann Thorac Surg, 88: e48-49.
17. Ahmed A, Aronow WS, Fleg JL (2006). Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J, 151: 444-450.
18. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al (2011). Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant, 30: 115-123.
19. Kumpati GS, McCarthy PM, Hoercher KJ (2001). Left ventricular assist device bridge to recovery: a review of the current status. Ann Thorac Surg, 71: S103-108.
20. Bramstedt KA (2001). Left ventricular assist devices and the slippery slope of ageism. Int J Cardiol, 81: 201-203.
21. Khazanie P, Rogers JG (2011). Patient selection for left ventricular assist devices. Congest Heart Fail, 17: 227-234.
22. Costanzo MR, Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, et al (2010). The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant, 29: 914-956.
23. Wilson SR, Mudge GH Jr, Stewart GC, Givertz MM (2009). Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation, 119: 2225-2232.
24. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, et al (2007). Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation, 116: 497-505.
25. Park SJ, Tector A, Piccioni W, Raines E, Gelijns A, Moskowitz A, et al (2005). Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg, 129: 9-17.
26. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, et al (2009). ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 119: 1977-2016.
27. Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, et al (2012). Recommendations for the use of mechanical circulatory support: Device strategies and patient selection: A scientific statement from the American Heart Association. Circulation, 126: 2648-2667.
28. Gilotra NA, Rusell SD (2012). Patient selection for mechanical circulatory support. Heart Fail Rev, Epub ahead of print, DOI: 10.1007/s10741-012093610-0.
29. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al (2009). Focused updated incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 119: e391-e479.
30. Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, et al (2010). HFSA 2010 comprehensive heart failure practice guideline. J Card Fail, 16: e1-e194.
31. Entwistle JWC, Sade RM, Petrucci RJ (2011). The ethics of mechanical support: the need for new guidelines. Ann Thorac Surg, 92: 1940.
32. Dobbels F, De Geest S, Van Cleemput J, Droogne W, Vanhaecke J (2004). Effect of late medication non-compliance on outcome after heart transplantation: a 5- year follow-up. J Heart Lung Transplant, 23: 1245-1251.
33. Cimato TR, Jessup M (2002). Recipient selection in cardiac transplantation: contraindications and risk factors for mortality. J Heart Lung Transplant, 21: 1161-1173.
34. Chacko RC, Harper RG, Gotto J, Young J (1996). Psychiatric interview and psychometric predictors of cardiac transplant survival. Am J Psychiatry, 153: 1607-1612.
35. Egerod I, Overgaard D (2012). Taking a back seat: support and self-preservation in close relatives of patients with left ventricular assist device. Eur J Cardiovasc Nurs, Epub ahead of print, DOI: 10.1177/1474515111435609.
36. Dobbels F, Vanhaecke J, Dupont L, Nevens F, Verleden G, Pirenne J, et al (2009). Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation, 87: 1497-1504.
37. Favaro A, Gerosa G, Caforio ALP, Volpe B, Rupolo G, Zarneri D, et al (2011). Posttraumatic stress disorder and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment. Gen Hosp Psychiatry, 33: 1-7.
38. Denollet J, Holmes RVF, Vrints CJ, Conraads VM (2007). Unfavorable outcome of heart transplantation in recipients with type D personality. J Heart Lung Transplant, 26: 152-158.
39. Arora S, Aukrust P, Andreassen A, Simonsen S, Gude E, Grov I, et al (2009). The prognostic importance of modifiable risk factors after heart transplantation. Am Heart J, 158: 431-436.
40. Olbrisch ME (1989). Psychology's contribution to relieving the donor organ shortage: barriers from within. Am Psychol, 44: 77-78.
41. Shapiro PA, Levin HR, Oz MC (1996). Left ventricular assist devices. Psychosocial burden and implications for heart transplant programs. Gen Hosp Psychiatry, 18: 30S-35S.
42. Petrucci RJ, Wright S, Naka Y, Idrissi KA, Russell SD, Dordunoo D, et al (2009). Neurocognitive Assessments in Advanced Heart Failure Patients Receiving Continuous-flow Left Ventricular Assist Devices. J Heart Lung Transplant, 28: 542-549.
43. Adamson RM, Stahovich M, Chillcott S, Baradarian S, Chammas J, Jaski B, et al (2011). Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: A community hospital experience. J Am Coll Cardiol, 57: 2487-2495.
44. Elwyn G, Edwards A, Kinnersley P (1999). Shared decision-making in primary care: the neglected second half of the consultation. Br J Gen Pract, 49: 477-482.
45. Rhymes JA, McCullough LB, Luchi RJ, Teasdale TA, Wilson N (2000). Withdrawing very low-burden interventions in chronically ill patients. JAMA, 283:1061-1063.
46. McCullough LB, Jones JW (2001). Postoperative futility: a clinical algorithm for setting limits. Br J Surg, 88: 1153-1154.
47. Goldstein NE, Lynn J (2006). Trajectory of end-stage heart failure: the influence of technology and implications for policy change. Perspect Biol Med, 49: 10-8.
48. Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, et al (2012). Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation, 125: 1928-1952.
49. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al (2006). The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation, 113: 1424-1433.
50. Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, et al (2011). Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes, 4: 389-398.
51. Krumholz HM, Anderson JL, Brooks NH, Fesmire FM, Lambrew CT, Landrum MB, et al (2006). ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation, 113: 732-761.
52. Keenan A-M, McKenna SP, Doward LC, Conaghan PG, Emery P, Tennant A (2008). Development and validation of a needs-based quality of life instrument for osteoarthritis. Arthritis Rheum, 59: 841-848.
53. Fitzpatrick III JR, Frederick JR, Hsu VM, Kozin ED, O'Hara ML, Howell E, et al (2008). Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant, 27: 1286-1292.
54. MacGowan GA, Kormos RL, McNamara DM, Alvarez RJ, Rosenblum WD, Pham S, et al (1998). Predicting short-term outcome in severely ill heart failure patients: Implications regarding listing for urgent cardiac transplantation and patient selection for temporary ventricular assist device support. Journal of Cardiac Failure, 4: 169-175.
55. Matthews JC, Pagani FD, Haft JW, Koelling TM, Naftel DC, Aaronson KD (2010). Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation, 121: 214-220.
56. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ (2005). Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA, 293: 572-580.
57. Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF Jr, et al (2004). Risk stratification after hospitalization for decompensated heart failure. J Card Fail, 10: 460-466.
58. Gorodeski EZ, Chu EC, Chow CH, Levy WC, Hsich E, Starling RC (2010). Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Circ Heart Fail, 3:706-714.
59. Rao BH, Saksena S (2003). Implantable cardioverter-defibrillators in cardiovascular care: technologic advances and new indications. Curr Opin Crit Care, 9: 362-368.
60. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM (1997). Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation, 95: 2660-2667.
61. Cowger J, Sundareswaran K, Rogers JG, Park SJ, Pagani FD, Bhat G, et al (2011). The HeartMate II risk score: Predicting Survival in candidates for left ventricular assist device support. J Heart Lung Transplant, 30: S31.
62. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al (2007). Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med, 357: 885-96.
63. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, et al (2009). Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol, 54: 312-21.
64. Teuteberg JJ, Ewald GA, Adamson RM, Lietz K, Miller LW, Tatooles AJ, et al (2012). Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients. J Am Coll Cardiol, 60: 44-51.
65. Faden RR, Beauchamp TL (1980). Decision-making and informed consent: a study of the impact of disclosed information. Soc Indic Res, 7: 313-336.
66. McCullough LB, Jones JW, Brody BA (1998). Informed consent: Autonomous decision making of the surgical patient. In: McCullough LB, Jones JW, Brody BA, editors. Surgical ethics. New York, NY: Oxford University Press, 15-36.
67. Pinney SP (2012). Timing isn't everything: donor heart allocation in the present LVAD era. J Am Coll Cardiol, 60: 52-53.
68. Stevenson LW, Hellkamp AS, Leier CV, Sopko G, Koelling T, Warnica JW, et al (2008). Changing preferences for survival after hospitalization with advanced heart failure. J. Am Coll Cardiol, 52: 1702-1708.
69. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW (2001). Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant, 20: 1016-1024.
70. Stanek EJ, Oates MB, McGhan WF, Denofrio D, Loh E (2000). Preferences for treatment outcomes in patients with heart failure: symptoms versus survival. J Card Fail, 6: 225-232.
71. Maciver J, Ross HJ (2012). Quality of life and left ventricular assist device support. Circulation, 126: 866-874.
72. Moskowitz AJ, Weinberg AD, Oz MC, Williams DL (1997). Quality of life with an implanted left ventricular assist device. Ann Thorac Surg, 64:1764-1769.
73. Dew MA, Kormos RL, Winowich S, Nastala CJ, Borovetz HS, Roth LH, et al (1999). Quality of life outcomes in left ventricular assist system inpatients and outpatients. ASAIO J, 45:218-225.
74. Catanese KA, Goldstein DJ, Williams DL, Foray AT, Illick CD, Gardocki MT, et al (1996). Outpatient left ventricular assist device support: a destination rather than a bridge. Ann Thorac Surg, 62: 646-652; discussion 653.
75. Ruzevich SA, Swartz MT, Reedy JE, Termuhlen DF, McBride LR, Frese SM, et al (1990). Retrospective analysis of the psychologic effects of mechanical circulatory support. J Heart Transplant, 9: 209-212.
76. Abou-Awdi NL, Frazier OH (1992). The HeartMate: a left ventricular assist device as a bridge to cardiac transplantation. Transplant. Proc, 24: 2002-2003.
77. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, et al (2010). Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol, 55: 1826-1834.
78. Grady KL, Meyer P, Mattea A, White-Williams C, Ormaza S, Kaan A, et al (2001). Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J. Heart Lung Transplant, 20: 657-669.
79. Grady KL, Meyer PM, Dressler D, Mattea A, Chillcott S, Loo A, et al (2004). Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Ann Thorac Surg, 77:1321-1327.
80. Grady KL, Meyer P, Mattea A, Dressler D, Ormaza S, White-Williams C, et al (2002). Predictors of quality of life at 1 month after implantation of a left ventricular assist device. Am J Crit Care, 11: 345-352.
81. Grady KL, Meyer PM, Dressler D, White-Williams C, Kaan A, Mattea A, et al (2003). Change in quality of life from after left ventricular assist device implantation to after heart transplantation. J Heart Lung Transplant, 22: 1254-1267.
82. Dew MA, Kormos RL, Winowich S, Stanford EA, Carozza L, Borovetz HS, et al (2000). Human factors issues in ventricular assist device recipients and their family caregivers. ASAIO J, 46: 367-373.
83. Wray J, Hallas CN, Banner NR. Quality of life and psychological well-being during and after left ventricular assist device support (2007). Clin Transplant, 21: 622-627.
84. Hallas C, Banner NR, Wray J (2009). A qualitative study of the psychological experience of patients during and after mechanical cardiac support. J Cardiovasc Nurs, 24: 31-39.
85. Allen JG, Weiss ES, Schaffer JM, Patel ND, Ullrich SL, Russell SD, et al (2010). Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. J Heart Lung Transplant, 29: 278-285.
86. Kugler C, Malehsa D, Tegtbur U, Guetzlaff E, Meyer AL, Bara C, et al (2011). Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. J Heart Lung Transplant, 30: 204-10.
87. George RS, Yacoub MH, Bowles CT, Hipkin M, Rogers P, Hallas C, et al (2008). Quality of life after removal of left ventricular assist device for myocardial recovery. J Heart Lung Transplant, 27:165-172.
88. Miller K, Myers TJ, Robertson K, Shah N, Delgado RM 3rd, Gregoric ID (2004). Quality of life in bridge-to-transplant patients with chronic heart failure after implantation of an axial flow ventricular assist device. Congest Heart Fail, 10: 226-229.
89. Oz MC, Gelijns AC, Miller L, Wang C, Nickens P, Arons R, et al (2003). Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg, 238: 577-583.
90. Chapman E, Parameshwar J, Jenkins D, Large S, Tsui S (2007). Psychosocial issues for patients with ventricular assist devices: a qualitative pilot study. Am J Crit Care, 16: 72-81.
91. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, et al (2007). Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol, 50: 741-747.
92. Green CP, Porter CB, Bresnahan DR, Spertus JA (2000). Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol, 35: 1245-1255.
93. Rector TS, Olivari MT, Levine TB, Francis GS, Cohn JN (1987). Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J, 114: 148-52.
94. Abbey SE, De Luca E, Mauthner OE, McKeever P, Shildrick M, Poole JM, et al (2011). Qualitative interviews vs standardized self-report questionnaires in assessing quality of life in heart transplant recipients. J Heart Lung Transplant, 30: 963-936.
95. Flint KM, Matlock DD, Lindenfeld J, Allen LA (2012). Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail, 5: 287.
96. Pellegrino ED (2000). Is it ethical to withdraw low-burden interventions in chronically ill patients? JAMA, 284:1380-1382.
97. Simon JR (2008). Case study. "Doctor, will you turn off my LVAD?" Commentary. Hastings Cent Rep, 38: 14-15.
98. Rady MY, Verheijde JL (2012). Ethical challenges with deactivation of durable mechanical circulatory support at the end of life: Left ventricular assist devices and total artificial hearts. J Intensive Care Med, Epub ahead of print, DOI: 10.1177/0885066611432415.
99. Mueller PS, Swetz KM, Freeman MR, Carter KA, Crowley ME, Severson CJA, et al (2010). Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc, 85: 791-797.
100. Sulmasy DP (2008). Within you/without you: biotechnology, ontology, and ethics. J Gen Intern Med, 1:69-72.
101. Jansen LA (2006). Hastening death and the boundaries of the self. Bioethics, 20: 105-111.
102. Fischbach RL (2008). Case study. "Doctor, will you turn off my LVAD?" Commentary. Hastings Cent Rep, 38: 15.
103. England R, England T, Coggon J (2007). The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer. J Med Ethics, 33: 538-540.
104. Herr SS, Bostrom BA, Barton RS (1992). No place to go: refusal of life-sustaining treatment by competent persons with physical disabilities. Issues Law Med, 8: 3-36.
105. Gill CJ (2004). Depression in the context of disability and the "right to die". Theor Med Bioeth, 25: 171-198.
106. Kirschner KL, Kerkhoff TR, Butt L, Yamada R, Battaglia CC, Wu J, et al (2011). "I don't want to live this way, doc. Please take me off the ventilator and let me die.' PMR, 3: 968-975.
107. Petrucci RJ, Benish LA, Carrow BL, Prato L, Hankins SR, Eisen HJ, et al (2011). Ethical considerations for ventricular assist device support: a 10-point model. ASAIO J, 57: 268-273.
108. Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS (2000). The last six months of life for patients with congestive heart failure. J Am Geriatr Soc, 48: S101-109.
109. Lynn J, Harrell F Jr, Cohn F, Wagner D, Connors AF Jr (1997). Prognoses of seriously ill hospitalized patients on the days before death: implications for patient care and public policy. New Horiz, 5: 56-61.
110. Lynn J, Goldstein NE (2003). Advance care planning for fatal chronic illness: avoiding commonplace errors and unwarranted suffering. Ann Intern Med, 138: 812-818.
111. Appelbaum PS (2007). Clinical practice. Assessment of patients' competence to consent to treatment. N Engl J Med, 357: 1834-1840.
112. Swetz KM, Freeman MR, AbouEzzeddine OF, Carter KA, Boilson BA, Ottenberg AL, et al (2011). Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin. Proc, 86: 493-500.
113. Goldstein NE, May CW, Meier DE (2011). Comprehensive care for mechanical circulatory support; a new frontier for synergy with palliative care. Circ Heart Fail, 2: 519-527.
114. Dunlay SM, Swetz KM, Mueller PS, Roger VL (2012). Advance directives in community patients with heart failure. Circ Cardiovasc Qual Outcomes, 5: 283-289.
115. Swetz KM, Mueller PS, Ottenberg AL, Dib C, Freeman MR, Sulmasy DP (2011). The use of advance directives among patients with left ventricular assist devices. Hosp Pract (Minneap), 39: 78-84.
116. Brush S, Budge D, Alharethi R, McCormick AJ, MacPherson JE, Reid BB, et al (2010). End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant, 29: 1337-1341.
117. Bogaev RC, Pamboukian SV, Moore SA, Chen L, John R, Boyle AJ, et al (2011). Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation. J Heart Lung Transplant, 30: 515-522.
118. Casida JM, Davis JE, Brewer RJ, Smith C, Yarandi H. Sleep and daytime sleepiness of patients with left ventricular assist devices: a longitudinal pilot study (2011). Prog Transplant, 21: 131-136.